Global Law Office has a longstanding reputation in the life sciences and healthcare sector, providing comprehensive services encompassing M&A, investment, licensing in and out and IP protection. The firm is home to a fully dedicated team, jointly led by Shanghai-based Alan Zhou, with over two decades of experience and is sought out by multinationals and large Chinese state-owned enterprises for his private equity and venture capital funds expertise, alongside Michael Yu in Beijing, specialising in M&A foreign direct investments and private equity investments to private and publicly owned medical institutions. The life sciences and financing offering was further strengthened with the hire of Andrew Chen in Shanghai, Shenbo Li and Chen Yang in Shenzhen, all of who joined from Arnold & Porter in September 2025. Other key lawyers include Jerry Liu, experienced in government regulatory compliance, while Coco Fan is well-versed in compliance relating to prescription medicine, medical devices and biopharmaceuticals. Charlene Huang recently led on matters involving outbound and inbound investment, private equity and state-owned acquisitions and restructuring of MNCs in the pharmaceutical and medical device sector. Rae Zhang is another name to note.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'The team is highly experienced in the pharmaceutical field and often gives practical advice to our clients.
- 'The team is very familiar with the legal compliance environment in the life and health field, and provides clients with the latest industry legal compliance trend analysis and risk balance advice.''
- 'Alan Zhou and his team responded very quickly, the quality of work was reliable, the service was thoughtful, and the cost performance was high.’
- 'Alan Zhou, Charlene Huang and Coco Fan are excellent partners in the global life sciences and healthcare team. They often give timely and practical advice to their clients. They are also very familiar with the legal and compliance environment within the industry and can advise clients on the balance of risk that meets the needs of the business. ’
Key clients
- Siemens
- Roche
- Abbott
- AstraZeneca
- GlaxoSmithKline China (GSK)
- Boehringer Ingelheim
- BMS
- Johnson & Johnson
- Sanofi
- Amgen
- Abbvie
- Hengrui
Work highlights
Representing Ablaze Pharma in completing the equity acquisition of Ablaze Pharma Chengdu Company by RayzeBio.
Supported Boehringer Ingelheim to enter into a broad strategic partnership with Sino-Biopharm in the field of oncology.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Coco Fan
Charlene Huang
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Alan Zhou; Michael Yu
Other key lawyers
Charlene Huang; Coco Fan; Andrew Chen; Shenbo Li; Chen Yang